| Connexin-43 regulates p38-mediated cell migration and invasion induced selectively in tumour cells by low doses of γ-radiation in an ERK-1/2-independent manner S Ghosh, A Kumar, RP Tripathi, S Chandna Carcinogenesis 35 (2), 383-395, 2014 | 60 | 2014 |
| A combination of approved antibodies overcomes resistance of lung cancer to osimertinib by blocking bypass pathways D Romaniello, L Mazzeo, M Mancini, I Marrocco, A Noronha, M Kreitman, ... Clinical Cancer Research 24 (22), 5610-5621, 2018 | 44 | 2018 |
| AXL and error-prone DNA replication confer drug resistance and offer strategies to treat EGFR-mutant lung cancer A Noronha, N Belugali Nataraj, JS Lee, B Zhitomirsky, Y Oren, S Oster, ... Cancer discovery 12 (11), 2666-2683, 2022 | 41 | 2022 |
| Roles for receptor tyrosine kinases in tumor progression and implications for cancer treatment S Ghosh, I Marrocco, Y Yarden Advances in cancer research 147, 1-57, 2020 | 38 | 2020 |
| Targeting HER3, a catalytically defective receptor tyrosine kinase, prevents resistance of lung cancer to a third-generation EGFR kinase inhibitor D Romaniello, I Marrocco, N Belugali Nataraj, I Ferrer, D Drago-Garcia, ... Cancers 12 (9), 2394, 2020 | 34 | 2020 |
| PD-L1 recruits phospholipase C and enhances tumorigenicity of lung tumors harboring mutant forms of EGFR S Ghosh, NB Nataraj, A Noronha, S Patkar, A Sekar, S Mukherjee, ... Cell reports 35 (8), 2021 | 30 | 2021 |
| Novel systemic treatment modalities including immunotherapy and molecular targeted therapy for recurrent and metastatic head and neck squamous cell carcinoma S Ghosh, PA Shah, FM Johnson International journal of molecular sciences 23 (14), 7889, 2022 | 29 | 2022 |
| Connexin-43 downregulation in G2/M phase enriched tumour cells causes extensive low-dose hyper-radiosensitivity (HRS) associated with mitochondrial apoptotic events S Ghosh, A Kumar, S Chandna Cancer Letters 363 (1), 46-59, 2015 | 25 | 2015 |
| Evidence for microRNA-31 dependent Bim-Bax interaction preceding mitochondrial Bax translocation during radiation-induced apoptosis A Kumar, S Ghosh, S Chandna Scientific reports 5 (1), 15923, 2015 | 24 | 2015 |
| ETS proteins bind with glucocorticoid receptors: Relevance for treatment of Ewing sarcoma S Srivastava, NB Nataraj, A Sekar, S Ghosh, C Bornstein, D Drago-Garcia, ... Cell Reports 29 (1), 104-117. e4, 2019 | 18 | 2019 |
| Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models I Marrocco, D Romaniello, I Vaknin, D Drago‐Garcia, R Oren, ML Uribe, ... EMBO Molecular Medicine 13 (4), e13144, 2021 | 14 | 2021 |
| Nucleoporin-93 reveals a common feature of aggressive breast cancers: robust nucleocytoplasmic transport of transcription factors NB Nataraj, A Noronha, JS Lee, S Ghosh, HRM Raju, A Sekar, ... Cell reports 38 (8), 2022 | 13 | 2022 |
| TSHZ2 is an EGF-regulated tumor suppressor that binds to the cytokinesis regulator PRC1 and inhibits metastasis ML Uribe, M Dahlhoff, RN Batra, NB Nataraj, Y Haga, D Drago-Garcia, ... Science signaling 14 (688), eabe6156, 2021 | 10 | 2021 |
| Targeting autocrine amphiregulin robustly and reproducibly inhibits ovarian cancer in a syngeneic model: roles for wildtype p53 M Lindzen, S Ghosh, A Noronha, D Drago, NB Nataraj, O Leitner, ... Oncogene 40 (21), 3665-3679, 2021 | 9 | 2021 |
| Inhibition of a pancreatic cancer model by cooperative pairs of clinically approved and experimental antibodies R Maron, B Schechter, NB Nataraj, S Ghosh, D Romaniello, I Marrocco, ... Biochemical and biophysical research communications 513 (1), 219-225, 2019 | 9 | 2019 |
| Combined TRIP13 and aurora kinase inhibition induces apoptosis in human papillomavirus–driven cancers S Ghosh, T Mazumdar, W Xu, RT Powell, C Stephan, L Shen, PA Shah, ... Clinical Cancer Research 28 (20), 4479-4493, 2022 | 8 | 2022 |
| Cisplatin S Ghosh the first metal based anticancer drug 88, 102925, 0 | 4 | |
| Effective SARS-CoV-2 vaccines on the horizon S Ghosh, PK Ghosh J Vaccines Vaccin 11, 428, 2020 | 3 | 2020 |
| Sustained Aurora kinase B expression confers resistance to PI3K inhibition in head and neck squamous cell carcinoma PA Shah, V Sambandam, AM Fernandez, H Zhao, T Mazumdar, L Shen, ... Cancer research 82 (23), 4444-4456, 2022 | 2 | 2022 |
| Rb deficient HPV+ HNSCC experienced enhanced sensitivity to aurora kinase inhibitors by altering the balance of MAD2 and TRIP13 levels S Ghosh, T Mazumdar, W Xu, RT Powell, C Stephan, L Shen, ... Cancer Research 82 (12_Supplement), 1858-1858, 2022 | 1 | 2022 |
Nishanth Belugali NatarajDepartment of Immunology and Regenerative Biology,Weizmann Institute of ScienceVerified email at weizmann.ac.il
